Press "Enter" to skip to content

New patent for Azurity drug KATERZIA

0
Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug KATERZIA

Annual Drug Patent Expirations for KATERZIA
Annual Drug Patent Expirations for KATERZIA

Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

KATERZIA drug price trends.

This drug has five patent family members in three countries.

The generic ingredient in KATERZIA is amlodipine benzoate. One supplier is listed for this compound. Additional details are available on the amlodipine benzoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug KATERZIA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions